MEOBF (Mesoblast) FCF Margin %: 0.00% (As of Dec. 2025)


MEOBF Mesoblast Ltd MEOBF
47 GF Score
Price $1.55
! 4 Warning Signs
View Full Analysis

What is Mesoblast FCF Margin %?

Mesoblast MEOBF 47 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates MEOBF with a GF Score™ of 47/100. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Mesoblast ranks worse than 64.75% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Mesoblast's Free Cash Flow for the three months ended in Dec. 2025 was $-15.57 Mil. Mesoblast's Revenue for the three months ended in Dec. 2025 was $0.00 Mil. Therefore, Mesoblast's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Mesoblast's current FCF Yield % is -2.82%.

The historical rank and industry rank for Mesoblast's FCF Margin % or its related term are showing as below:

MEOBF' s FCF Margin % Range Over the Past 10 Years
Min: -4927   Med: -544.79   Max: -185.39
Current: -304.71

During the past 13 years, the highest FCF Margin % of Mesoblast was -185.39%. The lowest was -4927.00%. And the median was -544.79%.

MEOBF's FCF Margin % is ranked worse than
64.75% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs MEOBF: -304.71

Mesoblast FCF Margin % Related Terms

Mesoblast FCF Margin % Historical Data

* Premium members only.

The historical data trend for Mesoblast's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesoblast FCF Margin % Chart

Mesoblast Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,377.40 -646.50 -847.66 -826.65 -294.71

Mesoblast Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MEOBF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Mesoblast's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mesoblast FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mesoblast's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Mesoblast's FCF Margin % falls into.


MEOBF
47GF Score
Mesoblast Ltd MEOBF
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mesoblast FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Mesoblast's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-50.684/17.198
=-294.71 %

Mesoblast's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-15.571/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Mesoblast (MEOBF) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mesoblast and its competitors. According to the industry distribution chart, Mesoblast ranks #621 out of 959 companies in the Biotechnology industry, placing it in the top 64.8%.
Is Mesoblast's FCF Margin % too high?
Mesoblast's current FCF Margin % is 0.00%. Based on the distribution chart, Mesoblast ranks #621 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Mesoblast has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Mesoblast's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Mesoblast ranks #621 out of 959 companies for FCF Margin %. This places Mesoblast in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mesoblast and its competitors. Mesoblast's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesoblast stock overvalued right now?
Mesoblast (MEOBF) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Mesoblast's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Mesoblast (MEOBF), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mesoblast Business Description

Address 55 Collins Street, Level 38, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
47GF Score

Get the complete analysis for MEOBF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.55
Price